Release Date: 29/01/18 17:33 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 211.54KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%